Large-scale testing (Phase 3)Study completedNCT04669028What this trial is testingNE3107 in Probable Alzheimer's DiseaseWho this might be right forAlzheimer Disease BioVie Inc. 439
Large-scale testing (Phase 3)Study completedNCT03860935What this trial is testingEfficacy and Safety of AG10 in Subjects With Transthyretin Amyloid CardiomyopathyWho this might be right forAmyloidosisAmyloid CardiomyopathyTransthyretin Amyloidosis+2 more Eidos Therapeutics, a BridgeBio company 632
Large-scale testing (Phase 3)Study completedNCT01872598What this trial is testingMasitinib in Patients With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer Disease AB Science 721
Large-scale testing (Phase 3)Ended earlyNCT00998764What this trial is testingA Long-Term Safety And Tolerability Extension Study Of Bapineuzumab In Alzheimer Disease PatientsWho this might be right forAlzheimer Disease Pfizer 494
Large-scale testing (Phase 3)Study completedNCT00574132What this trial is testingBapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)Who this might be right forAlzheimer's Disease JANSSEN Alzheimer Immunotherapy Research & Development, LLC 1,331
Large-scale testing (Phase 3)Looking for participantsNCT06937229What this trial is testingEvaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)Who this might be right forAlzheimer DiseaseAgitation Bristol-Myers Squibb 600
Large-scale testing (Phase 3)Study completedNCT02791230What this trial is testingLong-term Safety of Tafamidis in Subjects With Transthyretin CardiomyopathyWho this might be right forTransthyretin (TTR) Amyloid Cardiomyopathy Pfizer 1,733
Large-scale testing (Phase 3)Study completedNCT05542953What this trial is testing[18F]APN-1607 PET in Subjects With AD Compared to HCWho this might be right forAlzheimer's DiseaseMild Cognitive Impairment Due to Alzheimer's DiseaseHealthy Volunteers APRINOIA Therapeutics 230
Testing effectiveness (Phase 2)Study completedNCT00814346What this trial is testingEffect of EGb761® on Brain Glucose Metabolism in Three Groups of Elderly Defined by Cognitive FunctionsWho this might be right forAlzheimer's DiseaseCognitive Impairment Ipsen 49
Not applicableStudy completedNCT00660088What this trial is testingSafety of Three Formulations of Ketasyn Administered for 14 Days in Healthy ElderlyWho this might be right forAlzheimer's Disease Cerecin 60
Testing effectiveness (Phase 2)Study completedNCT00165659What this trial is testingA Multi-Center, Randomized, Double-Blind, Parallel Group Study With 3 Groups Receiving Placebo, 5 mg of E2020 and 10 mg of E2020Who this might be right forAlzheimer Disease Eisai Limited
Large-scale testing (Phase 3)Study completedNCT03393520What this trial is testingAssessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's TypeWho this might be right forAgitation in Patients With Dementia of the Alzheimer's Type Otsuka Pharmaceutical Development & Commercialization, Inc. 601
Testing effectiveness (Phase 2)UnknownNCT01953705What this trial is testingN-3 PUFA for Vascular Cognitive AgingWho this might be right forAge Related Cognitive DeclineAlzheimer's DiseaseVascular Dementia+2 more Oregon Health and Science University 102
Large-scale testing (Phase 3)Not Yet RecruitingNCT07422311What this trial is testingTo Evaluate the Efficacy, Safety, and Tolerability of Dronabinol Oral Solution for Agitation in Patients With Alzheimer's DiseaseWho this might be right forAgitation in Dementia Benuvia Therapeutics Inc. 140
Large-scale testing (Phase 3)Ended earlyNCT00322036What this trial is testingGlobal Efficacy Study of MPC-7869 to Treat Patients With Alzheimer'sWho this might be right forAlzheimer DiseaseDementia Myrexis Inc. 800
Early research (Phase 1)Study completedNCT01565330What this trial is testingTwo Doses of 18F-AV-45 in Alzheimer's Disease and Healthy VolunteersWho this might be right forAlzheimer Disease Avid Radiopharmaceuticals 20
Large-scale testing (Phase 3)Looking for participantsNCT06534723What this trial is testingPhase 3 Clinical Trial of Wujia Yizhi Granules in the Treatment of Mild-to-moderate Alzheimer's Dementia (Syndrome of Deficiency of Spleen and Kidney)Who this might be right forAlzheimer's Dementia Sichuan Jishengtang Pharmaceutical Co., Ltd. 570
Testing effectiveness (Phase 2)Study completedNCT01429623What this trial is testingA 3 Year Study to Evaluate the Safety and Efficacy of Low Dose Ladostigil in Patients With Mild Cognitive ImpairmentWho this might be right forMild Cognitive ImpairmentDementia Avraham Pharmaceuticals Ltd 210
Large-scale testing (Phase 3)Ended earlyNCT00667810What this trial is testingStudy Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease PatientsWho this might be right forAlzheimer Disease Pfizer 901
Large-scale testing (Phase 3)WithdrawnNCT04418024What this trial is testingEfficacy and Safety of AG10 in Subjects with Transthyretin Amyloid PolyneurophathyWho this might be right forTransthyretin-Related (ATTR) Familial Amyloid Polyneuropathy Eidos Therapeutics, a BridgeBio company